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Acquisition of the intestinal microbiota begins at
birth, and a stable microbial community develops
from a succession of key organisms. Disruption of
the microbiota during maturation by low-dose anti-
biotic exposure can alter host metabolism and
adiposity. We now show that low-dose penicillin
(LDP), delivered from birth, induces metabolic
alterations and affects ileal expression of genes
involved in immunity. LDP that is limited to early life
transiently perturbs the microbiota, which is suffi-
cient to induce sustained effects on body composi-
tion, indicating that microbiota interactions in infancy
may be critical determinants of long-term host meta-
bolic effects. In addition, LDP enhances the effect of
high-fat diet induced obesity. The growth promotion
phenotype is transferrable to germ-free hosts by
LDP-selected microbiota, showing that the altered
microbiota, not antibiotics per se, play a causal
role. These studies characterize important variables
in early-life microbe-host metabolic interaction and
identify several taxa consistently linked with meta-
bolic alterations.
INTRODUCTION
Obesity, a complex disease, can increase the risk of diabetes,
heart disease, and cancer (Vucenik and Stains, 2012). Along
with dietary excess and genetic polymorphisms, the trillions of
microbial cells in the intestinal microbiota can contribute to
obesity by increasing energy extraction (Turnbaugh et al.,2006) or by altering metabolic signaling (Samuel et al., 2008)
and inflammation (Cani et al., 2008; Henao-Mejia et al., 2012;
Vijay-Kumar et al., 2010). Obese and lean humans differ inmicro-
biota compositions, and these phenotypes can be transferred to
germ-free mice (Ley et al., 2005; Ridaura et al., 2013), high-
lighting the need for greater understanding of microbiota-host
metabolic interactions.
Because early life is a critical period for metabolic develop-
ment (Cunningham et al., 2014; Dietz, 1994; Knittle and Hirsch,
1968), microbiota disruption during this window could lead to
changes in body composition. In humans, early-life microbiota
disruption, either due to delivery by Caesarian section (Domi-
nguez-Bello et al., 2010) or antibiotics, is associated with
increased risk of overweight status later in childhood (Ajslev
et al., 2011; Blustein et al., 2013; Huh et al., 2012; Murphy
et al., 2013; Trasande et al., 2013), although in mice, antibiotic
exposure can increase or decrease weight, depending on the
dose, diet used, or strain (Dubos et al., 1963).
For decades, farmers have been exposing livestock to
low doses of antibiotics to promote growth; the earlier in
life that exposure begins, the more profound the effects (Crom-
well, 2002; http://www.fda.gov/animalveterinary/products/
approvedanimaldrugproducts/default.htm). We have applied
the agricultural model of growth promotion to interrogate funda-
mental host-microbe metabolic relationships. We previously
showed that early-life subtherapeutic antibiotic treatment in-
creased fat mass, altered metabolic hormones, hepatic meta-
bolism, and microbiota composition (Cho et al., 2012). Here,
we extend these studies using low-dose penicillin (LDP) as a
model agent disrupting the microbiota. We examined whether
timing of LDP exposure is critical, whether synergies exist
between penicillin and dietary effects, and whether the altered
microbiota is sufficient to yield metabolic phenotypes. Our ex-
periments answered each of these questions in the affirmative.Cell 158, 705–721, August 14, 2014 ª2014 Elsevier Inc. 705
Remarkably, we found that microbial communities recovered
after the cessation of antibiotics, yet the metabolic phenotypes
persisted, highlighting the importance of the early-life microbiota
in growth and development.
RESULTS
Effect of LDP Commencement Age on Growth
Phenotypes
Introducing LDP, chlortetracycline, or vancomycin to young
mice at weaning increased subsequent fat mass (Cho et al.,
2012). We now asked whether earlier exposure might have
more substantial effects. C57BL/6J mice were exposed to LDP
postweaning (LDP-w), or their mother received LDP shortly
before their pups’ birth (LDP-b) and through weaning, so that
the pups would be initially colonized with an altered maternal
microbiota and receive LDPwhile nursing. Control mice received
no antibiotic (Figure 1A). LDP did not reduce microbial popula-
tion size (Figure 1B), which is consistent with previous findings
(Cho et al., 2012). Prior to weaning, male LDP-b mice had accel-
erated growth (Figure 1C), and adult male LDP-b mice had
increased total and fat mass and decreased bone mineral con-
tent compared to controls (Figures 1D–1I). LDP-w male mice
showed similar trends; however, later LDP exposure had lesser
effects on body composition. Female LDP-b mice, but not
LDP-w, had significantly elevated total mass. Both female LDP
groups had significantly elevated bone mineral density. Similar
to DEXA, MRI showed increased body fat percentage in LDP-b
male mice (Figures 1J–1M) and also identified LDP-induced
ectopic fat deposition, including elevated total abdominal,
visceral, and liver adiposity, which is linked with metabolic syn-
drome (Blu¨her, 2010; Rasouli et al., 2007). Associated with the
trend of increased liver adiposity detected by MRI, LDP-b signif-
icantly increased hepatic expression of genes involved in adipo-
genesis, including Pparg, Cd36, and fatty acid binding protein 2
(Fabp2) (Figures 1N–1P), which is consistent with our prior ob-
servations (Cho et al., 2012). Contrastingly, the LDP-w mice
had reduced expression of genes involved in cholesterol meta-
bolism and fatty acid synthesis (Figures 1Q–1S) compared to
controls. This dichotomy may reflect the differences in pheno-
type development or that downregulation of genes involved in
lipid metabolism in the LDP-w mice explains why these mice
resist total and fat mass accumulation. In total, earlier penicillin
exposure led to enhanced metabolic phenotypes, suggesting
greater host vulnerability to microbiota disruption in infancy,
with more pronounced effects in male mice.
Dynamics of Phenotype Development and Microbiota
Alterations
We next conducted longitudinal studies to permit a dynamic
view of LDP-mediated phenotype development. Female and
male LDPmice showed faster fat accumulation (rate differential =
0.13% per week female [p = 0.002] and 0.15% per week male
[p = 0.02]) and with significant increases in body fat percent de-
tected earlier in males (Figures 2A–C). LDP reduced nonfasting
serum peptide YY, and there was a trend of increased leptin (Fig-
ures 2D and 2E), alterations typically seen in obesity (Grudell and
Camilleri, 2007; Morrison et al., 2009).706 Cell 158, 705–721, August 14, 2014 ª2014 Elsevier Inc.LDP significantly altered microbial community composition,
measured by unweighted UniFrac distances (b diversity) at all
time points examined (Figures 2F–2J). As the mice aged, posi-
tions of the control and LDP fecal samples changed unidirection-
ally on the principal coordinate analysis (PCoA) plots, with
greater differences in LDP mice, suggesting acceleration of the
normal age-related microbiota development. Intergroup b diver-
sity was significantly higher than either intragroup distances,
showing the distinctive LDP and control microbiota community
structures (Figure 2K).
The populations of mammalian microbiota show a pattern of
succession in early life (Pantoja-Feliciano et al., 2013; Schaedler
et al., 1965), and altered representations of particular taxa have
been associated with the development of obesity (Kallioma¨ki
et al., 2008). As expected, after nursing for 4 weeks, the control
microbiota was dominated by Lactobacillus, diminishing asmice
matured (Figures 2L–2N). Although LDP mice showed similar
age-dependent population shifts, Lactobacillus levels were
much lower at multiple time points than control. Focusing on
early life (week 4), broad population changes were seen from
phylum to genus level (Figure 2M). In addition to Lactobacillus,
LDP consistently reduced early-life Candidatus Arthromitus
(segmented filamentous bacteria, SFB) and Allobaculum levels
(Figures 2O and OP) across multiple independent experiments
(Tables S1 and Figure S1 available online). As expected (Davis
and Savage, 1976; Jiang et al., 2001), early-life populations of
Candidatus Arthromitus were highest in control pups and unde-
tectable in oldermice but were significantly reduced by LDP (Fig-
ure 2O). These temporal changes indicate that LDP suppresses
multiple taxa that typically peak early in life. Although high-dose
(therapeutic) antibiotic exposures reduce microbiota diversity in
animals and humans (Antonopoulos et al., 2009; Dethlefsen
et al., 2008), LDP increased phylogenetic diversity at 4 weeks
(Figure 2Q), which is consistent with decreases in particular
prominent taxa and detection of taxa with lower representation.
By sampling across time, we identified microbes that were
altered prior to the development of adiposity, suggesting roles
in host metabolic development.
Interaction between LDP and Dietary Excess
We next asked whether there were additive effects of early-life
LDP and increased caloric intake. Mice received either LDP or
not (control), were weaned to normal chow (NC), and at
17 weeks, half of the mice were switched to a high-fat diet
(HFD) (Figure 3A). In the males, total mass was increased by
LDP, more so by HFD, and most by the combination (Figure 3B).
In those fed NC, LDP increased lean mass, and in those given
HFD, LDP markedly increased fat mass (Figures 3C and 3D).
Fasting insulin was not altered by HFD alone, which may reflect
that 45% kcal from fat does not produce as extensive metabolic
effects as 60% kcal from fat (Pettersson et al., 2012). Insulin was
slightly, but not significantly, increased by LDP but was signifi-
cantly raised in mice receiving the combination (Figure 3E). In
female mice, total mass, not increased by HFD alone, was
increased by the combination of HFD and LDP, and lean mass
was increased by LDP on either diet. Most notably, by 30 weeks,
LDP approximately doubled the fat mass in females fed HFD
(Figures 3F–3H) but did not significantly alter fasting insulin
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Figure 1. Effect of Timing of Initial LDP Exposure on Body Composition
(A) Study design: C57B/L6Jmice received LDP (1 mg/g bodyweight) continuously for life either beginning at weaning at day 28 of life (LDP-w, n = 5male, 6 female),
or from birth (LDP-b, n = 5 male, 4 female). Control mice had no penicillin exposure (n = 6 male, 5 female).
(B) Levels of cecal bacteria at week 20 determined by quantitative PCR using universal bacterial 16S rRNA primers.
(C) Early-life (periweaning: day 21 to day 28) growth rate.
(D–I) Body composition and bone histomorphometry determined at week 20 by DEXA scanning.
(J) MRI representation of lean (gray) and fat (yellow) tissue and regions that were analyzed for hepatic and visceral fat (red).
(K) Adiposity (total body fat percent) determined by MRI in three male mice each in LDP-b and control groups at week 18.
(L and M) (L) Total abdominal, visceral, and subcutaneous fat volume and (M) liver adiposity (fat percent).
(N–S) Hepatic gene expression in week 20 male mice (n = 5–6/group). *p < 0.05, **p < 0.01, and ***p < 0.001, t test compared to control. Graphs are displayed as
mean ± SEM.
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(Figure 3I). In both male and female 26 week mice, LDP
increased abdominal fat, localized to the visceral compartment
(Figures 3J–3L). In total, these studies provide evidence that
LDP exposure enhances the HFD metabolic effects and confirm
prior observations (Goyal et al., 2012) that male mice are more
predisposed to diet-induced obesity.
Alterations in microbiota and diet can affect the liver (Henao-
Mejia et al., 2012). HFD significantly increased hepatic steatosis
in male and female mice at age 30 weeks, with greater increases
in males, and increased hepatocyte ballooning in male mice.
LDP reduced both metrics in male mice fed normal chow (Fig-
ures 3M–3O) and had little additive effect in mice fed HFD.
Neither LDP nor HFD strongly affected lobular inflammation or
fibrosis (Figures S2A and S2B). However, although the magni-
tude of the effect was small, LDP significantly increased inflam-
mation and fibrosis in female mice fed HFD. In total, histological
analyses indicate that HFD is a stronger driver of nonalcoholic
fatty liver disease (NAFLD) than LDP and that the extent of
HFD-mediated effects and LDP induced-inflammation differed
by gender.
At the transcriptional level, HFD had a stronger effect on
hepatic gene expression than LDP, and the dietary effect was
greatest in mice receiving LDP (Figure 3P). Of the 1,091 genes
uniquely regulated by HFD in LDPmice, 980 (90%) had a nonsig-
nificant trend in the same direction in control mice, indicating that
microbiome disruption could amplify HFD-mediated changes.
Through comparative analyses, we identified genes either
uniquely regulated by LDP or by HFD, requiring both interven-
tions, or responding synergistically (Figures 3Q–3R and S2O).
In mice fed HFD, LDP altered genes related to carbohydrate
metabolism and cell movement, which resembled the effects
of HFD in LDP-treated mice, but not HFD alone (Figures 3S
and S2C–S2N). In contrast, HFD alone or in combination with
LDP changed expression of genes related to glucose meta-
bolism (decreased) and to fatty acid metabolism and lipid syn-
thesis (increased). HFD-regulated genes in LDP mice were
involved in functions linked to the microbiota (Figure 3S), such
as increased immune and antigen-presenting cell responses
(Erturk-Hasdemir and Kasper, 2013), increased eicosanoid syn-
thesis and decreased arachidonate metabolism (Antunes andFigure 2. Dynamics of Microbiota and Adiposity Changes over 30 Wee
(A) Study design: female and male C57B/L6 mice received LDP (n = 10 males and
(B–E) (B andC) Body fat percent over time determined byDEXA scanning in female
male mice. *p < 0.05 significantly different by t test for (B)–(E) and (Q).
(F–Q) Fecal specimens obtained at weeks 4, 16, and 26, and the terminal (week 30
V1-2 region of the bacterial 16S rRNA gene.
(F–J) Principal coordinate analysis (PCoA) of unweighted UniFrac distances of
clustering assessed by ADONIS test.
(K) Divergence within (control versus control, LDP versus LDP) and between com
UniFrac matrix was permutated 10,000 times; p values represent fraction of time
and ***p < 0.001 significantly different from intragroup distance.
(L) Mean relative abundance of predominant bacteria (>1% in any sample) in contr
the letter preceding the underscore: o, order; f, family; g, genus; s, species.
(M) Cladograms, generated from LEfSe analysis, represent taxa enriched in contro
root of the tree (Bacteria), and each ring represents the next lower taxonomic lev
abundance of the taxon. When full identification was not possible, g_ or s_ alone
(N–P) Relative abundance of Lactobacillus, Candidatus Arthromitus (SFB), and Al
also Figure S1 and Table S1.
(Q) Phylogenetic diversity in control and LDP male mice (mean ± SEM), calculateFinlay, 2011), and increased vascularization (Stappenbeck
et al., 2002).
To examine microbiota changes, we studied serial fecal pel-
lets and terminal cecal and ileal samples (Figure 4A). Based on
unweighted UniFrac distances, both LDP and HFD significantly
(p < 0.05, ADONIS test) altered community structure (Figures
4B–4F), and HFD had larger effects on microbial community
structure than LDP. Regardless of antibiotic exposure, HFD led
to numerous enriched taxa in 30-week fecal samples, including
the phylum Firmicutes and lower lineages, and decreased
Bacteroidetes, as reported (Ley et al., 2005) (Figures S3A and
S3B). Regardless of diet, LDP modulated multiple taxa (Fig-
ure S3C), including Lactobacillus. Focusing on early life (Fig-
ure 4G), LDP affected multiple taxa, some of which were
consistently modulated across experiments (Table S1). Rikenel-
laceae levels, highest in control mice at 4 weeks, diminished with
age but were markedly reduced by LDP (Figure 4H). Levels of
genus Lactobacillus, comprised predominantly of L. reuteri and
L. vaginalis, also were reduced (Figures 4I–4J), although less
than prior (Figure 2N). These studies reveal that LDP and HFD
have independent selective effects, with LDP consistently linked
with specific microbial changes.
Early-Life Metabolic Programming: Limited Antibiotic
Exposures Lead to Durable Phenotypes
Hypothesizing that early life was the critical period for program-
ming host-microbe metabolic interactions, we sought to deter-
mine whether microbiota disruption limited to early life could
induce metabolic effects. In addition to long-term (28 week)
LDP or none (control), groups of mice received 4 or 8 weeks of
LDP (Figure 5A), and to accelerate metabolic phenotypes, all
were switched to HFD at 6 weeks of age. In female mice, all
LDP groups developed elevated total, lean, and fat mass
compared to controls, irrespective of LDP duration (Figure 5B).
Compared to controls, following switch to HFD, female LDP
mice had significantly elevated caloric intake (Figure 5C) and
significantly faster total and fat mass accumulation rates from
6 to 20 weeks of age (Table S2). Later in life (weeks 20–28), all
three LDP groups showed significantly slower rates in lean
mass growth compared to controls, indicating catch-up by theks of Life
females) or no antibiotics (control, n = 9 males and 10 females) for 30 weeks.
andmalemice. Serum levels of (D) peptide YY (PYY) and (E) leptin at week 30 in
) cecal and ileal specimens frommale mice were examined by sequencing the
the intestinal microbiota at each sample point; p values listed for differential
munities (control versus LDP) measured by unweighted UniFrac distance. The
s permuted differences were greater than real distances; *p < 0.05, **p < 0.01,
ol and LDPmice. Taxa are reported at the lowest identifiable level, indicated by
l (green) or LDP (red) 4-week fecal microbiota. The central point represents the
el (phylum through genus). The diameter of each circle represents the relative
was used for genus or species, respectively.
lobaculum; asterisks indicate level of significance by Mann-Whitney U test, see
d at a uniform depth of 4,000 sequences/sample.
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control mice. Male LDP mice showed early elevations in total,
lean, and fat mass but did not have increased food intake or
feed efficiency from 6 to 8 weeks of age (Figures S4A–S4D),
and the early-life changes in body composition were lost with
aging, which is consistent with increased early-life and gender-
dependent sensitivity to HFD (Goyal et al., 2012; Pettersson
et al., 2012), which may override microbe-mediated effects.
Disruption of defenses at the intestinal interface has been
implicated in obesity (Cani et al., 2008; Henao-Mejia et al.,
2012; Vijay-Kumar et al., 2010). By age 4 weeks, LDP induced
substantial histopathologic effects in ileal tissues, notably short-
ened villi (Figures 5D and 5E), which is consistent with changed
ileal architecture in LDP-mediated livestock growth promotion
(Gaskins et al., 2002; Visek, 1978). Transcriptional profiling anal-
ysis of intestinal tissue by microarray (Figure S4E) and subse-
quent validation by Nanostring analysis revealed that the ileal
atrophy from LDP was associated with a general decreased
expression of genes involved in intestinal immune responses,
with numerous consistencies across gender (Figure 5F and
Table S3). LDP decreased expression of genes related to several
biological functions, such as differentiation, activation, recruit-
ment, and adhesion of immune cells, and functions specifically
related to antigen-presenting cells, T cells, B cells, and phago-
cytic cells (Figure S4F).
The gut microbiota influences the composition of CD4+ T cells
within the intestinal mucosa (Hooper et al., 2012). LDP reduced
expression of transcription factors and cytokines important for
Th1 and Th17 cell differentiation and function (Figures 5G–5N),
with significant effects inmales and consistent trends in females.
Antimicrobial peptides b-defensin 1 (Defb1) and regenerating
islet-derived protein 3 gamma (RegIIIg) were also downregulated
by LDP (Figures 5O and 5P). To confirm the Th17 cell alterations,
we performed flow cytometric analysis on lamina propria cells
isolated from the ileum and colon in 8-week-old male mice.
These showed reduced CD4+ IL-17- or IL-22-positive cell popu-
lations after LDP (Figure 5Q). Taken together, these results
indicate that intestinal immune responses are globally reduced
after LDP.
Next, we examined the effects of limited early-life LDP on the
microbiota (Figure S5). By UniFrac analysis, the microbial com-
munities in the females were distinct between control and LDPFigure 3. Effects of Combining LDP and HFD
(A) Study design: Male and femalemice either received LDP from birth or did not re
were maintained on normal chow and half switched to a HFD at week 17.
(B–O) *p < 0.05, **p < 0.01, and ***p < 0.001, t test for (B)–(L); and Mann-Whitne
(B–H) Body composition consisting of total, lean, and fat mass in male and fema
(E and I) Fasting insulin in week 30 mice.
(J–L) Distribution of abdominal body fat, determined by MRI at week 26 (n = 5–6
(J) Images show representative male mice; numbers represent the volume of tot
(K–L) Abdominal adiposity, quantified by total, visceral, and subcutaneous fat in
(M–O) Hepatic histopathology: (M) Representative hematoxylin and eosin (H&E)
(P–S) Hepatic gene expression, measured by microarray in male mice at 30 wee
(P) Number of genes that have significant (FDR-adjusted p < 0.05) hepatic express
or downregulated in the underlined group with respect to the nonunderlined gro
(Q) Comparative analysis of differential hepatic gene expression. Venn diagram
parisons, LDP effect in HFD mice (LDP versus CTL), diet effect in control mice (H
(R) Heatmaps depict gene expression values of Venn regions I–III (see also Figur
(S) Predicted biological functions that are differentially represented, (p < 0.05, z- sc
hepatic gene expression.from the earliest time point studied (3 weeks) to the end of the
experiment (28 weeks) (Figures 6A–6C, ADONIS test, Table
S4). However, after antibiotic cessation, community structure
progressively reverted to normal in the fecal, cecal, and ileal
samples. To assess community structure patterns according to
age, we examined intragroup phylogenetic distances. In infancy,
themicrobiota of control mice are highly diverse, becomingmore
homogeneous as mice age, a pattern that is also observed in all
LDP groups (Figure 6D and Table S5). After antibiotic cessation,
microbiota from the 4-LDP and 8-LDP mice become no more
distant from the control mice than the intragroup control varia-
tion, demonstrating recovery; however, the 28- (continuous)
LDP microbiota divergence never normalized (Figure 6E and
Table S5), and in the complementary analyses, as expected,
the opposite pattern was observed (Figure 6F). All told, the
community analyses demonstrate early-life individual host
microbiota variability that decreases during maturation and
that microbial populations are only transiently disrupted by
limited duration LDP, yet the effects on phenotype are lifelong
(Figure 5B).
LDP induced numerous compositional changes in the micro-
biota (Figure 6G), and HFD had further effects. After HFD was
started, control mouse Allobaculum markedly increased with
concomitant decreases in Akkermansia mucinophila and an
unidentified Bacteroidales S24-7 family member. After antibiotic
cessation in the 4-LDP and 8-LDP mice, the patterns associated
with HFDexposure of the control mice began to emerge but were
never present in the 28-LDP mice. The persistent phenotypes
after LDP cessation, despite microbiota normalization, provide
evidence that the early-life microbiota influences adult body
composition. LDP suppressed early-life Lactobacillus, Allobacu-
lum, Rikenellaceae, and Candidatus Arthromitus (SFB) (Figures
6H and 6I) as observed in the prior experiments (Table S1),
further implicating them as candidate protective taxa; these
organisms were positively correlated with markers of ileal immu-
nity (Figure 5J).
LDP-Altered Microbiota Are Sufficient to Induce
Metabolic Changes
Although the above observations suggest that the change in the
microbiota is driving the metabolic and immunologic effects,ceive antibiotics (control, CTL). All mice were started on a NCdiet, and then half
y U for (N) and (O). Graphs are displayed as mean ± SEM.
le mice determined by DEXA.
each).
al (T), visceral (V), and subcutaneous (S) fat mass in three consecutive slices.
three consecutive cross-sections in female and male mice.
-stained sections. (N and O) Steatosis and hepatocyte ballooning scores.
ks of age (n = 3 in each of the four exposure groups).
ion differences comparing either LDP treatment or dietary changes that are up-
up.
indicates the number of overlapping genes in three separate pairwise com-
FD versus NC) and diet effect in LDP mice (HFD versus NC).
e S2 for regions IV–VI).
ore > j2j) based on Ingenuity Pathway Analysis of microarray measurements of
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they also could reflect the influence of the administered LDP on
development. To eliminate the direct effects of penicillin, we
transferred cecal microbiota from 18-week-old female control
or LDP mice (n = 3 each) (Figure 7A) to 3-week-old female
germ-free Swiss-Webster mice. Although the strains of murine
microbiota donor and germ-free recipient were not the same,
this approach has been used to test the causality of altered
microbiota between differing mouse strains (Vijay-Kumar et al.,
2010) and host species (humans and mice) (Ridaura et al.,
2013). The LDP-microbiota recipients increased total mass and
fat mass at a faster rate (rate differential = 0.078 g per day total
[p = 0.01], 0.058 g per day fat [p = 0.0012]) compared to controls;
no changes were detected in lean mass (Figure 7B). These
findings indicate that the host metabolic changes are driven by
the LDP-alteredmicrobiota and are not dependent on direct anti-
biotic effects on the host.
As we now expected, the LDP microbiota donor mice had
decreased ileal expression of genes involved in Th17 popula-
tions and antimicrobial peptides (Figure 7C). At 8 weeks of
age, the LDP-microbiota recipients showed similar trends to
the donor mice (Figure 7D). The LDP-altered microbiota also
changed immunological gene expression compared to the
recipients of the control microbiota (Figure 7E), and these
changes were related to predicted biological functions similarly
altered in the 8-week-old male and female mice directly exposed
to LDP (Figure S4F), including decreased differentiation, acti-
vation, adhesion, recruitment, and quantity of immune cells.
These studies provide evidence that altered microbiota can
mediate changes in intestinal immune gene expression and are
consistent with the global reduction in intestinal immune re-
sponses observed in the LDP-exposed microbiota donors (Fig-
ures 5F–5Q).
In contrast to the conserved ileal gene expression functional
changes with LDP, hepatic gene expression was more specific
to the experimental conditions (Figures S4G and S4H and Table
S3). Nevertheless, we found consistencies, such as genes
related to organismal death in males and females directly
exposed to LDP, but few such differences were also observed
in the transfer experiment (Figure S4I).
Microbe-Host Associations in Microbe-Induced Obesity
In the absence of further antibiotic selective pressure, the
recipient-microbiota communities remained distinct, based on
their respective donors (Figures 7F–7I and Table S6). Next,
we asked whether specific taxa were differentially represented
in the transfer recipients in the early time points (1–14 days
posttransfer), prior to detected phenotype development. LEfSeFigure 4. The Effect of HFD and LDP on Intestinal Microbiota Compos
(A) Study design: control (C) mice did not receive antibiotics; LDP (P) mice receive
switched to HFD (F) at week 17. Microbiota samples were collected longitudinal
(B–E) PCoA of fecal microbiota samples at weeks 4, 16, 18, and 30; p values for
(F) Mean pairwise intra- and intergroup unweighted UniFrac distances of week
intragroup distances, p < 0.05 based on 10,000 permutations.
(G) Cladogram representing taxa enriched in 4 week fecal samples in control or
(H–J) Relative abundance of Rikenellaceae, Lactobacillus reuteri, and Lactobacill
0.001, Mann-Whitney U test. Graphs are displayed as mean ± SEM.
See also Figure S3.analysis (Figure 7I) identified many of the same taxa as in
prior experiments (Table S1), including Lactobacillus, Allobacu-
lum, and Rikenellaceae (Figures 7J–7L). These organisms were
negatively correlated with total and/or fat mass (Figure 7M)
and positively correlated with expression of the Th17 tran-
scription factor Rorgt and cytokine Il17f and antimicrobial
peptides RegIIIg and Relmb, which is consistent with prior
experiments.
Predicted metagenomic analysis, performed using PICRUSt
(Langille et al., 2013), showed substantial commonalities at
multiple time points and across experiments (Figure S6). In
particular, recipients of LDP or of LDP-microbiota showed
increased representation of predicted Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathways involved in protein and
lipid biosynthesis, whereas the control and control-microbiota
recipient mice were predicted to have increased carbohydrate
and terpenoid biosynthesis pathway representation. These re-
sults indicate potential functional shifts reflecting the composi-
tional differences.
Microbe-Induced Obesity Is Limited in Sequential
Transfers
Finally, to address whether the LDP growth promotion effect
would continue after a period of recovery from antibiotic selec-
tive pressure, a second microbiota transfer to germ-free mice
was performed. Cecal microbiota were collected from three con-
trol-microbiota recipients (CR1) or LDP-microbiota recipients
(PR1) at 8 weeks of age, pooled, and transferred to new groups
of germ-free mice (CR2 and PR2) (Figure S7A). At 23 days post-
transfer, both the CR2 and PR2micewere lean compared to PR1
mice, with no significant adiposity differences over 2 months
(Figures S7B–S7E). Although the CR2 and PR2 mice continued
to have distinct fecal microbial community structures, intergroup
distances were decreased compared to the first transfer, and
the candidate protective taxa were not suppressed in the
PR2 recipients (Figures S7F–S7L and Table S1). Thus, in a
sequential transfer without direct antibiotic exposure, there
was normalization of the metabolic and the ecologic pheno-
types; the restoration of Lactobacillus, Allobaculum, and Rike-
nellaceae populations further strengthens the evidence for a
putative protective role.
DISCUSSION
We have proposed microbe-induced obesity (MIO) as a condi-
tion in which excessive adiposity results from primary perturba-
tion of themicrobiota, in contrast to diet-induced obesity (DIO) orition
d LDP from birth. All mice were started on normal chow (N), and then half were
ly for 16S rRNA sequencing.
differential clustering assessed by ADONIS test are indicated in the insets.
30 fecal microbial, letters a–d indicate significant differences with respect to
LDP mice, detected be the LEfSe tool.
us vaginalis in fecal samples from weeks 4–30; *p < 0.05, **p < 0.01, and ***p <
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gene-induced obesity (GIO) (Cox and Blaser, 2013). We had
developed a mouse model of MIO, showing that subtherapeutic
antibiotic treatment (including LDP) delivered at weaning led to
increased adiposity (Cho et al., 2012). We now indicate five
characteristics of MIO. First, early life is the critical window of
host-microbe metabolic interaction, in which preweaning micro-
biota perturbation promotes growth and is sufficient for lasting
metabolic changes. Second, even with exposures limited to
infancy, the elevated adiposity emerges later, in early to mida-
dulthood. Third, penicillin exposures amplify DIO and effects
on hepatic gene expression, metabolic hormone levels, and
visceral fat accumulation. Fourth, the altered microbiota alone,
not continued LDP exposures, is causal. That germ-free
chickens do not gain weight in response to low-dose penicillin
also provides evidence that the penicillin-altered microbiota
drives metabolic changes (Coates et al., 1963). Fifth, the trans-
missibility of the phenotype is lost with successive transfers,
indicating that phenotypic recovery is possible when antibiotic
exposure stops. In total, our work extends the MIO concept
and defines key features of the model.
We performed our studies using penicillin, a b-lactam anti-
biotic, the class most frequently prescribed to children in the
US and worldwide (Chai et al., 2012; Clavenna and Bonati,
2011). As in other animal models of disease, we found variability
in the timing and extent of phenotype emergence with notable
gender differences (Markle et al., 2013; Pettersson et al., 2012;
Yurkovetskiy et al., 2013). Nevertheless, LDP consistently
enhanced growth, affecting lean, fat, or bone or a combination
thereof.
We also have identified key microbiota characteristics in this
MIO model. First, consistent with our earlier findings (Cho
et al., 2012), LDP exposure was not associated with reduced
microbial abundance or taxonomic diversity, indicating that
compositional differences drive MIO. Second, after antibiotic
cessation, the microbiota returns to a normal population struc-
ture; however, metabolic consequences last, providing evidence
that early-life microbiota participate in long-term metabolic pro-
gramming. Third, particular organisms were consistently under-
represented in LDP mice prior to phenotype development (Table
S1), suggesting that their loss during a critical window is detri-
mental. These findings are consistent with prior studies showing
that early life changes in metabolism or exposure to antibiotics
predict later adiposity in rodents (Knittle and Hirsch, 1968) and
humans (Ajslev et al., 2011; Murphy et al., 2013; Trasande
et al., 2013).Figure 5. Early-Life LDP Induces Lasting Changes in Adult Body Comp
(A) Study design: both male and female mice received 4 (4-LDP), 8 (8-LDP), or 2
(B) Total, lean, and fat mass in female mice, measured by DEXA scanning. *p < 0.0
LDP mice had significantly increased rates of total and fat mass accumulation fr
(C) Cumulative food intake for female mice over 12 days during weeks 6 to 8 (n =
(D) Histopathology: representative H&E-stained ileal sections with villus atrophy
(E) Mean ± SEM ileal atrophy score in male control and LDP mice (n = 5 each) a
(F–P) (F) Expression of ileal genes that are significantly altered by LDP in both ma
Mouse Immunology Kit, genes shown p < 0.05, t test (see also Table S3). Ileal e
four T-helper cell lineages, and expression of antimicrobial peptides (O and P) me
n = 4 each.
(Q) Flow cytometry of ileal and colonic tissue from male control and LDP mice a
See also Figure S4. Graphs are displayed as mean ± SEM.Among the four candidate protective organisms, modulation
of host metabolism by Lactobacillus (Beijerinck, 1901) is known
(Million et al., 2012), whereas the associations with Allobaculum,
Rikenellaceae, and Candidatus Arthromitus (SFB) are novel.
Finding associations with the recently described Allobaculum
(Greetham et al., 2004), recently classified family Rikenellaceae
(Collins et al., 1985), and with the long-known (Leidy, 1849)
(but not yet cultured) SFB indicate the ability of sequence-based
approaches to identify new host-microbe interactions. All micro-
biota members do not equally impact the host; prior studies indi-
cate that these four organisms have either metabolic and/or
immunologic interactions (Daniel et al., 2014; Ivanov et al.,
2009; Karlsson et al., 2011; Martı´nez et al., 2009; Ravussin
et al., 2012), which may contribute to the observed protection
from weight gain in the control animals.
MIO could be mediated by alterations in the liver or the intes-
tine. Although our results confirm the previously observed late-
life hepatic effects (Cho et al., 2012), such as altered expression
of genes involved in fatty acid metabolism (e.g., Cd36, Pparg,
and Fabp2), there were few changes conserved in young males
and females and in microbiota recipients. This suggests that
the large number of hepatic gene expression changes in the
30 week males may be a consequence, rather than a cause, of
obesity. Nevertheless, our studies show that LDP increased liver
adiposity, visceral fat accumulation, and fasting insulin, indi-
cating that microbiota disruption can worsen obesity-related
complications.
Ileal changes are associated with altered hepatic gene expres-
sion and increased adiposity; reduced epithelial tight junction
proteins (Cani et al., 2008), loss of inflammasome function
(Henao-Mejia et al., 2012), lowered microbial surveillance (in
TLR5/mice; [Vijay-Kumar et al., 2010]), or thinning of the intes-
tinal mucus layer (Everard et al., 2013) can enhance translocation
of bacterial products and drive systemic inflammation and
obesity. The associations we observed of reduced ileal integrity
and expression of intestinal defense genes are consistent with
the prior studies and provide the complementary model of
MIO, in addition to models that manipulate host genetic or die-
tary factors.
LDP suppressed genes involved in antibacterial responses,
with processes involved in antigen presentation, Th17 cell differ-
entiation, and bacterial killing. One explanation invokes inhibited
colonization by highly interactive bacteria such as SFB, known to
be penicillin sensitive (Davis and Savage, 1976), that promote
Th17 gut responses (Ivanov et al., 2009). Regardless of SFBosition
8 (28-LDP) weeks of LDP or no antibiotics (control).
5 significant difference at a single time point measured by t test. 4-, 8-, and 28-
om 6–20 weeks of age (Table S2).
4 mice/group in metabolic cages).
scores 0–3.
t 4 weeks of age, *p < 0.05 Mann-Whitney U for (C) and (E).
le and female mice (n = 4 each) at 8 weeks of age, measured by the Nanostring
xpression of transcription factors (G–J) and cytokines (K–N) representative of
asured by qPCR; p values shown for t tests for 8 week male and female mice,
t 8 weeks of age (n = 4) for IL-17 and IL-22, *p < 0.05, t test.
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involvement in initial immunologic programming, other organ-
isms also stimulate Th17 responses because SFB were absent
from both control and LDP-microbiota recipients, which show
altered Th17 markers. Two (Lactobacillus and Allobaculum) of
the three other candidate protective taxa positively correlate
with RORgT and IL-17 expression, suggesting roles in intestinal
Th17 differentiation. However, although there are fewer Th17
cells and diminished expression of genes involved in intestinal
immune responses after LDP, our observations do not provide
causal evidence that LDP is directly altering intestinal immune
responses. Nevertheless, these findings are consistent with prior
studies that have identified impaired intestinal barrier function
and immunity as important factors in the development of meta-
bolic syndromes (Cani et al., 2008; Henao-Mejia et al., 2012;
Vijay-Kumar et al., 2010).
The metabolic consequences observed indicate that micro-
biota disruption during a critical developmental window can
explain later life phenomena, including adult obesity. LDP may
decrease particular early-life-protective bacterial populations,
which is consistent with coevolution with microbes having spe-
cific interactions promoting metabolic fitness (Blaser, 2006). As
‘‘keystone’’ species, their reduction could lead to broad intesti-
nal ecologic changes, permitting increases in taxa having alter-
nate roles in metabolic or immunologic development (Chung
et al., 2012). That the microbiota recovers, yet the phenotype re-
mains, suggests that microbiota changes can affect metabolic
programming; studies examining epigenetic regulation could
help elucidate mechanisms of host-microbe interaction.
Epidemiologic studies provide evidence that antibiotic expo-
sures in human infancy can lead to increased weight later in
life (Ajslev et al., 2011; Murphy et al., 2013; Trasande et al.,
2013). Combining multiple mouse models with high-throughput
microbial 16S rRNA profiling, we identified key microbiota mem-
bers impacted by antibiotic treatment and linked with host phys-
iologic changes. If humans have analogous organisms, their loss
in early life due to collateral antibiotic effects may have life-long
consequences. Restoration of lost taxa following early-life antibi-
otic exposures is a potential strategy to reverse MIO and related
sequelae. Nevertheless, humans have greater dietary and life-
style variation than do experimental mice, which introduces
factors that affect recovery frommetabolic disruption or suscep-
tibility to weight gain. Further studies are needed to examine
specific metabolic interactions of key members of the early-life
microbiota and to determine whether these changes are impor-
tant in humans.Figure 6. Effect of Limited Early-Life LDP on the Intestinal Microbiota
(A–C) PCoA of the unweighted UniFrac distances computed from 16S rRNA sequ
receiving either 4, 8, or 28 weeks of LDP or not receiving antibiotics (control).
(D–F) Intragroup and intergroup divergence measured by unweighted UniFrac di
(G) Relative abundance of themajor taxa (>1% in any sample) in the intestinal micr
of HFD.
(H) Phylogenetic representation of the taxa in the week 3, 3.5, and 4 fecal sam
by LEfSe.
(I) Relative abundance of Lactobacillus, Allobaculum, Rikenellaceae, and Candi
mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, Mann-Whitney U.
(J) Spearman correlation of relative abundance of early-life (weeks 3–8) Lactob
expression of ileal genes involved in intestinal defense. *p < 0.05 and **p < 0.01.
See also Figure S6 and Tables S4 and S5.EXPERIMENTAL PROCEDURES
Animals
All animal experiments were performed according to IACUC-approved proto-
cols. LDP was delivered via drinking water as described (Cho et al., 2012).
Control mice did not receive antibiotics. Diets used in the studies were either
NC (Purina Mills International Diet 5001, 13.5% kcal from fat), or HFD (Rodent
Diet D12451, Research Diets, 45% kcal from fat). For the microbiota transfer
experiments, cecal contents were collected from three microbiota donors
from each group and placed in a prereduced anaerobically sterilized liquid
dental transport medium (Anaerobe Systems, Morgan Hill), pooled in sterile
prereduced saline under anaerobic conditions, and then transferred to 3- to
4-week-old germ-free Swiss Webster mice via oral gavage (control recipients
n = 7; LDP recipients n = 8). The microbiota recipient mice were housed in
autoclaved cages under specific pathogen-free conditions and fed irradiated
HFD, as the donor mice had been. See Extended Experimental Procedures
for details on individual experiments.
Body Composition Analysis
Body composition was determined using dual energy X-ray absorptiometry
(DEXA) with a Lunar PIXImus II mouse densitometer (GE Medical Systems,
Waukesha) and by MRI on a 7-tesla MRI system (Bruker Biospin MRI,
Ettlingen). For theMRI, fat and lean tissues were determined using the iterative
decomposition of water and fat with an echo asymmetry and least-squares
(IDEAL) method (Reeder et al., 2004, 2005).
Hepatic and Ileal Gene Expression Profiling
Total RNA was extracted by the RNeasy Mini Kit (QIAGEN, Valencia). For
microarrary analysis, expression profiling was performed using the Affymetrix
Genechip Chip Mouse 430_2 system (Affymetrix, Santa Clara). The rawmicro-
array data were normalized using the Robust Multi-Array (RMA) method
(Irizarry et al., 2003). The Limma package in R was used to fit a linear
model to the expression data using empirical Bayes moderated t statistics
(Smyth, 2004). RNA-seq libraries were generated using the TruSeq v2 RNA
sample prep (Illumina, San Diego); libraries were sequenced with 2 3 50 bp
paired-end reads in an Illumina HiSeq 2500. Fastq files were processed as
follows: alignment was done with STAR (Dobin et al., 2013) with an index
build from the mm10 reference sequence. The genes annotated in UCSC
mm10 were quantified with HTSeq-count v0.5.3p9 (Anders et al., 2014).
Differential expression analysis was performed with the Bioconductor pack-
age DESeq (Anders and Huber, 2010). Ileal gene expression was measured
by the nCounter GX Mouse Immunology Kit (Nanostring Technologies,
Seattle).
Flow Cytometry
Lamina propria mononuclear cells were isolated from the ileum and colon.
Cells were stimulated with 50 ng/ml phorbol 12-myristate 13-acetate (PMA)
and 500 ng/ml Ionomycin for 4 hr at 37C in the presence of brefeldin A
(GolgiPlug, Becton Dickinson, Franklin Lakes). Following this in vitro stimula-
tion, cells were stained with LIVE/DEAD Fixable Aqua (Life Technologies),
anti-CD3, and anti-CD4 and fixed in 4% paraformaldehyde in PBS and then
permeabilized in Perm/Wash buffer (Becton Dickinson) and stained withences from (A) week 3, (B) week 8, (C) and week 28 microbiota in female mice
stances over time.
obiota. Dotted lines show cessation of antibiotics, and the solid line shows start
ples significantly associated with control (green) or LDP (red), as determined
datus Arthromitus (SFB) in 3–4 week fecal samples. Graphs are displayed as
acillus, Allobaculum, Rikenellaceae, and Candidatus Arthromitus (SFB) with
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anti-IL-17A and anti-IL-22 (eBioscience, San Diego). Cells were acquired on an
LSRII (Becton Dickinson) and analyzed with FlowJo (Tree Star, Ashland)
software.
Microbial Community Analysis
DNA was extracted using the MoBio PowerSoil DNA Extraction Kit, and the
microbial 16S rRNA gene was amplified with barcoded fusion primers, target-
ing either the V1-2 (Fierer et al., 2008) or the V4 (Caporaso et al., 2012) region
(Figure S5 and Table S7). The QIIME pipeline (Caporaso et al., 2010) was used
for quality filtering of DNA sequences, demultiplexing, taxonomic assignment,
and calculating a and b diversity. Metagenomic content of themicrobiota sam-
ples was predicted from the 16S rRNA profiles, and KEGG pathway functions
were categorized at level 3 using the phylogenetic investigation of commu-
nities by reconstruction of unobserved states (PICRUSt) tool (Langille et al.,
2013). Linear discriminant analysis effect size (LEfSe) (Segata et al., 2011)
was used to detect significant changes in relative abundance of microbial
taxa and predicted KEGG pathways between control and LDP mice.
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